Q2 FY2026 · ended Jun 30, 2026 · Revenue $2.44M, +10.2% YoY · Filed Aug 14, 2026
Lifeloc Technologies, Inc. (LCTC) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $2.4 million and a net loss of $134,330. Free cash flow was -$133,212. As of Jun 30, 2026 it held $908,208 in cash and investments and $1.0 million in total debt.
Revenue
$2.44M
+10.2% vs year-ago quarter
Net income
$-134,330
+65.9% vs year-ago quarter
Operating cash flow
$-133,212
+53.9% vs year-ago quarter
Free cash flow
$-133,212
+54.8% vs year-ago quarter
EPS
$-0.05
+64.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
2.75M
+0.0% vs year-ago quarter
Net cash
$-122,156
Q2 FY2026
Operating margin
-8.7%
TTM
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- LCTC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Wheat Ridge, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1493137
- Former names
- Lifeloc Technologies Inc (until Mar 29, 2012)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $2.4M | $2.3M | $2.3M | $2.3M | $2.2M |
| Operating income | -$103,576 | -$128,002 | -$336,881 | -$234,326 | -$378,265 |
| Net income | -$134,330 | -$152,713 | -$1.5M | -$263,439 | -$393,639 |
| Diluted EPS | -$0.05 | -$0.06 | -$0.55 | -$0.10 | -$0.14 |
| Operating cash flow | -$133,212 | -$129,365 | $79,118 | -$188,861 | -$289,219 |
| Free cash flow | -$133,212 | -$134,735 | -$344,165 | -$222,909 | -$294,681 |
| Total assets | $7.1M | $6.7M | $6.7M | $8.3M | $8.6M |
| Total liabilities | $3.3M | $2.8M | $2.6M | $2.7M | $2.7M |
| Stockholders' equity | $3.8M | $4.0M | $4.1M | $5.6M | $5.9M |
| Cash and investments | $908,208 | $569,330 | $746,001 | $685,097 | $995,750 |
| Total debt | $1.0M | $1.0M | $1.1M | $1.1M | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Auditor change, Shareholder vote results
|
Jun 5, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 19, 2026 | May 15, 2026 |
All 247 Lifeloc Technologies, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.